Eating your way to a healthy body !!

Did you know that there are hidden medicinal powers in some common Spring/Summer fruits? Here are just a few for starters.

Grape - Rich in antioxidant, anticancer compounds. Red grapes, (but not white or green grapes) are high in antioxidant quercetin. Grape skins contain resveratrol, shown to inhibit blood platelet clumping (and consequently, blood clot formation) and boost good-type HDL cholesterol. Red grapes are antibacterial and antiviral in test tubes. Grapeseed oil also raises good-type HDL cholesterol.

Grapefruit - The pulp contains a unique pectin (in membranes and juice sacs-not in juice) that lowers blood cholesterol and reverses atherosclerosis (clogged arteries) in animals. Has anticancer activity and appears particularly protective against stomach and pancreatic cancer. The juice is antiviral. High in various antioxidants, especially disease-fighting vitamin C.

Kiwi - Commonly prescribed in Chinese traditional medicine to treat stomach and breast cancer. High in vitamin C, which has multiple antidisease activity.

Pineapple - Suppresses inflammation. Both the fruit and a main constituent, an antibacterial enzyme called bromelain, are anti-inflammatory. (Great for those swelled ankles we sometimes get in the heat of the summer.) Pineapple aids digestion, helps dissolve blood clots and is good for preventing osteoporosis and bone fractures because of its very high manganese content. It is also antibacterial and antiviral and mildly estrogenic.

Watermelon - High amounts of lycopene and glutathione, antioxidant and anticancer compounds. Also mild antibacterial, anticoagulant activity.
About the Author

Modern Sage [ www.modernsage.com ] is online health journal to learn about living a healthy lifestyle, alternative medicine. Arun Tibrewal [ www.arun.info ] is an online marketing promotions specialist since 1998. Permission is granted to reprint this article as long as the resource box should keep intact http://www.modernsage.com >> living a healthy lifestyle, alternative medicine. http://www.arun.info >> Honest Online Marketing Guide

Written by: Arun Tibrewal

Updates and Recent News

Nicotine May Contribute To Breast Cancer's Spread
LOS ANGELES -- Nicotine may spur the spread of breast cancer, pushing cells from the original tumor to other parts of the body, said a study published in the latest issue of Cancer Research, a journal of the American Association for Cancer Research. Although scientists need time to pinpoint the exact role nicotine may play in breast cancer's spread, there is no doubt that nicotine may contribute to the metastasis that so often kills patients, according to the study published earlier this month. Besides serving as yet another warning against smoking, the finding may also point to new targets for cancer drugs, said the study conducted by researchers at Beth Israel Deaconess Medical Center and Harvard Medical School, Bost.
To Read More...

Two Treatments Similar In Breast Cancer
Results from a clinical trial comparing the effectiveness of the drugs paclitaxel and docetaxel, delivered over two different dosing schedules, showed that both drugs - regardless of the dosing schedules tested in this trial - provided similar benefits for women with stage II or III, operable breast cancer. However, more women treated with docetaxel than with paclitaxel experienced serious side effects from their therapy. The trial was led by the Eastern Cooperative Oncology Group in collaboration with the Cancer and Leukemia Group B, North Central Cancer Treatment Group (NCCTG), and the Southwest Oncology Group. The National Cancer Institute (NCI), part of the National Institutes of Health, supported this Phase III randomized clinical trial. The results were presented at the San Antonio Breast Cancer Symposium on December 8, 2005. ..
To Read More...

Tamoxifen Chemoprevention Associated With Earlier Diagnosis Of ER-Negative Breast Cancer
Women at elevated risk of breast cancer who had been randomly assigned to tamoxifen treatment and then developed estrogen receptor (ER) negative breast cancer were diagnosed earlier than women who had been randomly assigned to take a placebo and then developed ER-negative disease, according to a study published online October 7 in the Journal of the National Cancer Institute. Tamoxifen has been shown to reduce the risk of ER-positive breast cancer in women at high risk of disease. The drug does not alter the risk of ER-negative disease. In the current study, Yu Shen, Ph.D., of the University of Texas M. D. Anderson Cancer Center in Houston and colleagues performed a retrospective analysis of the Breast Cancer Prevention Trial to deter.
To Read More...